Abstract
Peanut oral immunotherapy (OIT) induces significant changes in peanut-specific immunoglobulin E (IgE) in peanut-allergic subjects, and most peanut-allergic individuals completing therapy safely ingest approximately 20 peanuts.1,2 Approximately one third of peanut-allergic individuals are allergic to tree nuts,3 and the effect of peanut OIT on other allergen-specific IgE is unknown. Because cross-reactivity exists between seed storage proteins in peanut and allergens present in almond4 and sesame,5 we hypothesized that peanut OIT would induce a significant decrease in almond- and sesame-specific IgE but would not affect cashew- and walnut-specific IgE.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
